EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dysregulation of miR-122, miR-574 and miR-375 in Egyptian patients with breast cancer

Eman A Elghoroury, Esmat E Abdelghafar, Solaf Kamel, Eman Awadallah, Aliaa Shalaby, Gamila S M El-Saeed, Eman Mahmoud, Mahmoud M Kamel iD, Asmaa Abobakr, Rasha Nazih Yousef

PLOS ONE · 31.05.2024 · 19 (5) · e0298536

DOI: 10.1371/journal.pone.0298536 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 31.05.2024. Verfasst von Eman A Elghoroury und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical & Chemical Pathology, Medical Research and Clinical Studies Institute, National Research Center, Giza, Egypt. Hauptthemen laut MEDLINE: MicroRNAs, Breast Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Centre-Egypt.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The early detection of breast cancer (BC) is receiving global attention, creating an urgent need for more sensitive and comprehensive strategies for preventive intervention, therapy assessment, and prognosis prediction. Aberrant expression of miRNAs has been observed in various malignancies and may be potential targets for therapy. Our study aims to examine the expression profiles of miR-375 , miR-574-3p , and miR-122 in the sera of Egyptian women with BC, benign breast lesions, and a control group. We hope to determine if these miRNAs can serve as minimally invasive biomarkers for BC.

Methods

This is a case-control study in which 77 patients with newly diagnosed BC, 20 patients with benign breast tumors, and 30 normal healthy subjects as controls were recruited from the outpatient clinic of the National Cancer Institute. The assessment of miRNAs was conducted using RT-PCR (Applied Biosystems).

Results

The expression level of miRNA-122 was significantly upregulated in the BC group, while the expression levels of miRNA-574 and miRNA-375 showed significant downregulation in BC patients. Serum miR-122 and miRNA-375 were able to distinguish breast cancer from the benign and control groups in ROC curve analysis, with AUCs of 0.786 and 0.796, respectively. Our results also showed that serum miR-122 and miR-574 are significant predictor variables in the multivariate analysis, after adjusting for age.

Conclusions

Our findings suggest that miR-122 may act as an onco-microRNA, while miR-574 and miR-375 may have a main tumour suppressor role. The studied miRNAs may serve as minimally invasive biomarkers for cases of breast cancer and as promising potential therapeutic targets for breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsBreast NeoplasmsBiomarkers, TumorHumansFemaleEgyptMiddle AgedAdultCase-Control StudiesGene Expression Regulation, NeoplasticROC CurveAged

Substanzen

MicroRNAsMIRN122 microRNA, humanMIRN375 microRNA, humanBiomarkers, TumorMIRN574 microRNA, human

Autor:innen und Institutionen

  • Department of Clinical & Chemical Pathology, Medical Research and Clinical Studies Institute, National Research Center, Giza, Egypt.
  • Medical Biochemistry, Medical Research and Clinical Studies Institute, National Research Center, Giza, Egypt.
  • Clinical Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
  • Baheya Centre for Early Detection and Treatment of Breast Cancer, Giza, Egypt.

ORCID-Profile: Mahmoud M Kamel

Förderung

  • National Research Centre-Egypt

Zitieren

APA

Elghoroury, E. A., Abdelghafar, E. E., Kamel, S., Awadallah, E., Shalaby, A., El-Saeed, G. S. M., Mahmoud, E., Kamel, M. M., Abobakr, A., & Yousef, R. N. (2024). Dysregulation of miR-122, miR-574 and miR-375 in Egyptian patients with breast cancer. PLOS ONE, 19(5), e0298536. https://doi.org/10.1371/journal.pone.0298536

Vancouver

Elghoroury EA, Abdelghafar EE, Kamel S, Awadallah E, Shalaby A, El-Saeed GSM, et al. Dysregulation of miR-122, miR-574 and miR-375 in Egyptian patients with breast cancer. PLOS ONE. 2024;19(5):e0298536. doi:10.1371/journal.pone.0298536

BibTeX
@article{Elghoroury2024,
  author = {Elghoroury, Eman A and Abdelghafar, Esmat E and Kamel, Solaf and Awadallah, Eman and Shalaby, Aliaa and El-Saeed, Gamila S M and Mahmoud, Eman and Kamel, Mahmoud M and Abobakr, Asmaa and Yousef, Rasha Nazih},
  title = {Dysregulation of miR-122, miR-574 and miR-375 in Egyptian patients with breast cancer},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {5},
  pages = {e0298536},
  doi = {10.1371/journal.pone.0298536}
}
Kostenlos starten →